Obstetrics

Steady declines in preterm birth are good news but there are more newborn lives to save.

Obese patients should be advised to avoid excessive weight gain in pregnancy.

A patient sues, claiming that an ob consult could have saved her pregnancy.

An expert commentary on ACOG Practice Bulletin Number 148: Thyroid disease in pregnancy.

A cesarean triggered by a steep drop in FHR reveals a surprising diagnosis.

A study looks at a possible connection between dilatation and curettage (D&C) and preterm birth.

Using SSRI late in pregnancy may increase the risk of persistent pulmonary hypertension in a newborn. Plus, hormone therapy may help mood in early postmenopause; use of mesh for prolapse on the rise

From the Society for Maternal-Fetal Medicine, questions and answers about cfDNA for your patients.

The ethical, economic, and practice management challenges associated with advanced testing increase as the technology advances.

A patient sues after a hysterectomy is performed even after a finding of no cancer.

Limited patient access to care and financial penalties to high-risk providers may be unintended consequences of this payment system.

A look at the evidence shows that a program using ob/gyn hospitalists makes sense for many facilities and may improve outcomes.

The professional responsibility model of obstetric ethics provides a powerful antidote to maternal rights-based reductionism.

Training on the devices is available, even beyond residency.

"The infant’s father testified that at the birth, he arrived 2 ½ hours prior to delivery, and for the duration of that time he was able to see his son’s head."

The USPSTF updated recommendations on mammography have sparked discussion on screening in younger women. Plus, does exposure to gestational diabetes increase risk of autism? What are the implications of genome editing?

NASPAG 29th conference featured research on the increased risk of complications in teen pregnancy, the desire on over-the-counter contraception, and a tool to help identify patients with menorrhagia.

DNA from a genetically dissimilar deceased twin may be counted as part of total fetal DNA, leaving to incorrect test results for the surviving fetus.

A recent report sheds light on how much false-positives and overdiagnosis of breast cancer cost. Additionally, new research examines the impact of the number of live births on future heart health in the mother and provides further evidence of the efficacy of cfDNA testing.

A review of the causes, surveillance options, and management strategies for the pregnancy at risk of fetal anemia.

Hospital births and obstetricians are not the enemies of low-intervention spontaneous vaginal delivery.

Knowledge of fetal lung maturity provides useful adjunctive information that is unique and relevant to a patient.

Cardiovascular problems can complicate pregnancy, and pregnancy can reveal cardiovascular risks.

A form of assisted reproductive technology that could make it possible for women with mutations in mitochondrial DNA to give birth to children free of mitochondrial disease has been approved by UK’s House of Commons. A Food and Drug Administration (FDA) committee is considering granting similar approval for use of the technique-known as oocyte modification or three-parent gene therapy-in the United States.

Contemporary OB/GYN provides information on the latest research from SMFM's annual Pregnancy Meeting.